ASKA Pharmaceutical Holdings
4886.TTSE PRIMEPharmaceutical
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| Dalton Investments, Inc. | 10.03% |
| NIPPON ACTIVE VALUE FUND PLC | 8.34% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| - | 3.60% |
| NAVF Select (Master) Fund LP | 2.95% |
| NAVF Select LLC | 2.85% |
| - | 1.95% |
| - | 0.38% |
Ownership history · 48
| Holder | Ratio | Change |
|---|---|---|
| Dalton Investments, Inc.2024-07-19 | 2.10% | +0.89pp |
| NIPPON ACTIVE VALUE FUND PLC2024-07-19 | 4.96% | +0.10pp |
| Dalton Investments, Inc.2024-04-15 | 1.21% | +0.31pp |
| NAVF Select LLC2024-04-15 | 1.63% | +0.15pp |
| NIPPON ACTIVE VALUE FUND PLC2024-04-15 | 4.86% | +0.70pp |
| Dalton Investments, Inc.2024-04-04 | 0.90% | new |
| NAVF Select LLC2024-04-04 | 1.48% | new |
| NIPPON ACTIVE VALUE FUND PLC2024-04-04 | 4.16% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.